4
Changes in Ownership
Rani Therapeutics Holdings, Inc. Filed Acc 0000950170-23-071473
Options or other derivatives
- Chief Scientific Officer acquired 328,374 shares (grant or award)
- Chief Scientific Officer returned 328,374 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Hashim Mir Chief Scientific Officer | 2023-12-16 | Returned to the company · Stock Option (Right to Buy) | −171,500 | 34,300 | D: show line 1 in the form | |||||
| Hashim Mir Chief Scientific Officer | 2023-12-16 | Grant or award · Stock Option (Right to Buy) | +171,500 | 171,500 | D: show line 2 in the form | |||||
| Hashim Mir Chief Scientific Officer | 2023-12-16 | Returned to the company · Stock Option (Right to Buy) | −73,150 | 52,250 | D: show line 3 in the form | |||||
| Hashim Mir Chief Scientific Officer | 2023-12-16 | Grant or award · Stock Option (Right to Buy) | +73,150 | 73,150 | D: show line 4 in the form | |||||
| Hashim Mir Chief Scientific Officer | 2023-12-16 | Returned to the company · Stock Option (Right to Buy) | −83,724 | 127,788 | D: show line 5 in the form | |||||
| Hashim Mir Chief Scientific Officer | 2023-12-16 | Grant or award · Stock Option (Right to Buy) | +83,724 | 83,724 | D: show line 6 in the form |
Loading xslF345X05/ownership.xml…